Lu TX - Search Results

1

Clinical characteristics and prognostic value of pre-retreatment plasma epstein-barr virus DNA in locoregional recurrent nasopharyngeal carcinoma.

Liu MZ, Fang SG, Huang W, Wang HY, Tian YM, Huang RD, Sun Z, Zhao C, Lu TX, Huang Y, Han F. Liu MZ, et al. Among authors: lu tx. Cancer Med. 2019 Aug;8(10):4633-4643. doi: 10.1002/cam4.2339. Epub 2019 Jul 3. Cancer Med. 2019. PMID: 31268626 Free PMC article.

2

Temporal lobe injury after re-irradiation of locally recurrent nasopharyngeal carcinoma using intensity modulated radiotherapy: clinical characteristics and prognostic factors.

Liu S, Lu T, Zhao C, Shen J, Tian Y, Guan Y, Zeng L, Xiao W, Huang S, Han F. Liu S, et al. J Neurooncol. 2014 Sep;119(2):421-8. doi: 10.1007/s11060-014-1513-3. Epub 2014 Jul 2. J Neurooncol. 2014. PMID: 24986091

3

Prognostic significance of tumor volume in locally recurrent nasopharyngeal carcinoma treated with salvage intensity-modulated radiotherapy.

Xiao W, Liu S, Tian Y, Guan Y, Huang S, Lin C, Zhao C, Lu T, Han F. Xiao W, et al. PLoS One. 2015 Apr 30;10(4):e0125351. doi: 10.1371/journal.pone.0125351. eCollection 2015. PLoS One. 2015. PMID: 25927527 Free PMC article.

4

The efficacy and safety of Endostar combined with chemoradiotherapy for patients with advanced, locally recurrent nasopharyngeal carcinoma.

Guan Y, Li A, Xiao W, Liu S, Chen B, Lu T, Zhao C, Han F. Guan Y, et al. Oncotarget. 2015 Oct 20;6(32):33926-34. doi: 10.18632/oncotarget.5271. Oncotarget. 2015. PMID: 26418895 Free PMC article.

5

Elevated plasma fibrinogen level shows superior prognostic value than Epstein-Barr virus DNA load for stage IVA/B nasopharyngeal carcinoma patients in the intensity-modulated radiotherapy era.

Lan M, Chen C, Huang Y, Mao M, Han F, Liao J, Deng M, Duan Z, Zheng L, Wu S, Lu T, Jian Y. Lan M, et al. Oncotarget. 2016 Jul 19;7(29):46242-46252. doi: 10.18632/oncotarget.10083. Oncotarget. 2016. PMID: 27323828 Free PMC article.

6

Prognostic efficacy of combining tumor volume with Epstein-Barr virus DNA in patients treated with intensity-modulated radiotherapy for nasopharyngeal carcinoma.

Lu L, Li J, Zhao C, Xue W, Han F, Tao T, Chang H, Jia W, Lu T. Lu L, et al. Oral Oncol. 2016 Sep;60:18-24. doi: 10.1016/j.oraloncology.2016.06.013. Epub 2016 Jun 30. Oral Oncol. 2016. PMID: 27531868

7

[Intensity modulated radiation therapy for 49 patients with recurrent nasopharyngeal carcinoma].

Lu TX, Zhao C, Han F, Huang Y, Deng XW, Lu LX, Zeng ZF, Huang SM, Lin CG, Cui NJ. Lu TX, et al. Among authors: lu lx. Zhonghua Zhong Liu Za Zhi. 2003 Jul;25(4):386-9. Zhonghua Zhong Liu Za Zhi. 2003. PMID: 12921573 Chinese.

8

[Intensity modulated radiotherapy for local-regional advanced nasopharyngeal carcinoma].

Zhao C, Han F, Lu LX, Huang SM, Lin CG, Deng XW, Lu TX, Cui NJ. Zhao C, et al. Among authors: lu lx, lu tx. Ai Zheng. 2004 Nov;23(11 Suppl):1532-7. Ai Zheng. 2004. PMID: 15566674 Chinese.

9

[Correlation of DNA ploidy in fresh tumor tissues to prognosis of nasopharyngeal carcinoma].

Han F, Wang HY, Xia YF, Liu MZ, Zhao C, Lu TX. Han F, et al. Among authors: lu tx. Ai Zheng. 2007 Sep;26(9):1015-9. Ai Zheng. 2007. PMID: 17927864 Free article. Chinese.

10

Treatment outcomes after radiotherapy alone for patients with early-stage nasopharyngeal carcinoma.

Xiao WW, Han F, Lu TX, Chen CY, Huang Y, Zhao C. Xiao WW, et al. Among authors: lu tx. Int J Radiat Oncol Biol Phys. 2009 Jul 15;74(4):1070-6. doi: 10.1016/j.ijrobp.2008.09.008. Epub 2009 Feb 21. Int J Radiat Oncol Biol Phys. 2009. PMID: 19231110

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

179 results

Search Page

Filters